We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Regeneron Pharmaceuticals Inc | NASDAQ:REGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
12.88 | 1.19% | 1,094.99 | 1,091.00 | 1,100.00 | 1,100.08 | 1,079.0855 | 1,087.89 | 282,365 | 23:07:22 |
By James Willhite
Here's what we're watching ahead of the opening bell on Monday.
-- Futures tied to the S&P 500 slipped 0.6%, indicating the benchmark may fall from the all-time high it closed at on Friday. Contracts tied to the Nasdaq-100 edged 0.5% lower and those linked to the Dow Jones Industrial Average fell 0.7%.
Political rancor remains front and center, as the House may move to impeach President Trump as soon as this week.
What's Coming Up
-- Atlanta Fed President Raphael Bostic speaks on the economic outlook at 12 p.m., and Dallas Fed President Robert Kaplan speaks at a virtual town hall at 6 p.m.
Investors say the recent rise in Treasury yields is raising questions about how the central bank may respond. The yield on the 10-year Treasury note on Monday edged down to 1.101%, from 1.105% Friday.
-- Ford and General Motors are presenting at the Morgan Stanley Auto 2.0 Conference. Participants at the JPMorgan Healthcare Conference will include Novartis, AstraZeneca and Regeneron Pharmaceuticals.
Market Movers to Watch
-- Ahead of the bell, Twitter shares dropped 6.3%. The social-media site permanently banned President Trump, perhaps one of its most famous users. Facebook shut him out as well.
-- Eli Lilly shares jumped more than 14% premarket after it said an experimental Alzheimer's drug helped patients in a small trial.
-- Shares of Sarepta Therapeutics clawed back 6.8% premarket after plummeting more than 50% on Friday.
-- U.S. listed shares of Chinese electric-car maker NIO extended their recent climb, adding 10% premarket after Friday's more than 8% jump. The company on Saturday unveiled its fourth production model.
-- Shares in Gilead Sciences rose 1.7% after the drug maker raised its product sales expectations for 2020 as it said it sold more remdesivir, the Covid-19 drug, amid a recent surge in coronavirus cases.
-- Bitcoin prices on Monday are down more than 8% to trade below $35,000. Just last week the volatile digital currency had been trading north of $40,000.
Market Fact
While the Dow climbed 7.2% in 2020 and the S&P 500 wrapped up the year with a gain of more than 16%, the average diversified U.S. stock fund rewarded investors with a 19.1% increase.
Chart of the Day
Investors are showing signs of increasing exuberance, reflecting optimism about a vaccine-fueled global recovery and the changed economics of the post-coronavirus world.
Must Reads Since You Went to Bed
TikTok, Discord Are the New Wall Street Trading Desks
Ban on Chinese Stocks Prompts Banks to Delist Derivatives
Cold Snap Sparks Record Rise in Natural Gas Prices in Asia
Stripe Stops Processing Payments for Trump Campaign Website
(END) Dow Jones Newswires
January 11, 2021 07:57 ET (12:57 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Regeneron Pharmaceuticals Chart |
1 Month Regeneron Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions